Abortion Pill

18 Jun

Abortion Pill Access Is Still Under Threat After SCOTUS Ruling, Legal Experts Warn

MollyLatest News, United States, , , , , ,
"....Last week’s ruling was widely expected, legal experts say. “Anybody that values reproductive freedom and the scientific integrity of the [U.S. Food and Drug Administration] can breathe a sigh of relief,” says Lawrence Gostin, a professor of global health law at Georgetown University. But “it would be foolish to declare victory” for abortion rights, he says. The ruling was a narrow legal technicality that didn’t go into the case’s actual merits. It’s quite possible, Gostin says, that the Court could make future rulings that restrict access to medication abortion and usurp the FDA’s broader authority to regulate drug safety...."
Read More
02 Apr

Supreme Court Skeptical of Push to Curb Access to Abortion Pill

MollyLatest News, United States, , , ,
"In the 2022 case of Dobbs v. Jackson Women’s Health Organization, the U.S. Supreme Court overturned Roe v. Wade and held that there is no constitutional right to an abortion, returning the legality of abortion to the states. The court must now decide if access to mifepristone, the drug used in medication abortions, should be restricted. During oral arguments last week, most of the justices seemed reluctant to roll back access to the drug. Instead, they focused on whether the plaintiffs had a legal right, or standing, to sue and questioned whether the doctors in the case, Food and Drug Administration v. Alliance for…
Read More
07 Feb

U.S. publisher retracts studies cited by Texas judge in suspending abortion pill’s approval

MollyLatest News, United States, , , , , , , ,
"A U.S. scientific publisher has retracted two studies, largely due to their methodology, that a Texas judge cited last year in his ruling suspending federal approval of the abortion pill mifepristone in response to a lawsuit by anti-abortion doctors and medical associations. The retraction Monday by Sage Publications came less than two months before the U.S. Supreme Court is expected to hear an appeal by President Joe Biden's administration in that case. Mifepristone, the first in a two-pill regimen for medication abortion, remains available while the appeal is pending...."
Read More
23 Jan

In Washington state, pharmacists are poised to start prescribing abortion drugs

MollyLatest News, United States, , , , , , ,
"Over the past several months, a handful of community pharmacies in states where abortion remains legal have begun to take advantage of a new rule that allows them to fill prescriptions for the abortion pill mifepristone. Prior to the rule change, which was finalized last January by the Food and Drug Administration, pregnant people had to get the drug directly from their doctor or by mail if using telemedicine, depending on the laws in their state. Reproductive health experts have said relaxing that requirement could help ease the growing burden on abortion clinics in states where abortion is legal. And perhaps nowhere is the potential for…
Read More
14 Dec

Supreme Court agrees to hear showdown over abortion pill access

MollyUnited States, , , , ,
"The Supreme Court on Wednesday took up a high-stakes legal battle that could lead to a definitive decision on whether the drug most commonly used for medication abortions will continue to be easily available, including by mail. The court agreed to weigh appeals from the Biden administration and drugmaker Danco defending several Food and Drug Administration decisions that made it easier to access and use the mifepristone pill. Danco makes the brand version of the pill, Mifeprex...."
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.